Name | Gemtuzumab |
---|
Description | Gemtuzumab (Gemtuzumab ozogamicin) is an antibody-drug conjugate (ADC) consisting of a monoclonal antibody targeting CD33 linked to a cytotoxic derivative of Calicheamicin. Gemtuzumab can be used for the research of acute myeloid leukemia[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |